Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-51.36	106.39	218.74
Graham Fair Price	68.11	2.51	1.49
PEG	-87.15	0.16	-1.23
Price/Book	0.84	2.68	2.66
Price/Cash Flow	-99.35	-126.14	19258.80
Prices/Earnings	-65.94	38.14	111.98
Price/Sales	30.06	14.85	11.42
Price/FCF	-99.35	-126.14	19258.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.12	0.38	0.40
Operating Margin	249.66	0.13	0.04
ROA	190.82	0.01	< 0.005
ROE	< 0.005	0.02	196.05
ROIC	< 0.005	0.02	270.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.28	-0.40	-30.25
Dividends QOQ	0.13	-0.55	317.20
EBIT QOQ	-0.86	1.77	105.17
EPS QOQ	-0.91	2.41	165.09
FCF QOQ	-0.99	-158.17	-15809.17
Revenue QOQ	-0.06	-0.21	-248.61
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	89.00	133.02	49.45
Days Sales Outstanding (DSO)	61.03	68.62	12.43
Inventory Turnover	1.01	0.68	-33.09
Debt/Capitalization	0.14	0.17	20.84
Quick Ratio	1.47	1.34	-8.75
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.08	3.99	-2.30
Cash	1.31	1.34	2.08
Capex	-0.19	-0.17	11.58
Free Cash Flow	< 0.005	-0.08	14942.88
Revenue	0.95	0.72	-24.25
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.95	1.86	-4.67
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.60	-5.89	59.69
Naive Interpretation	Member

06 - Financial Health · Weak

Rating